Related Experiment Videos
Fluctuations in response to L-dopa in Parkinson's disease may be explained by changes in striatal dopamine turnover
1University Department of Neurology, Institute of Psychiatry, London, U.K.
British Journal of Pharmacology
|December 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New insights into the cause of Parkinson's disease.
Neurology·1992
The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry·1992
Fronto-striatal cognitive deficits at different stages of Parkinson's disease.
Brain : a journal of neurology·1992
"Isolated" postinfectious myoclonus.
Journal of neurology, neurosurgery, and psychiatry·1992
Striatal neuropeptide levels in Parkinson's disease patients.
Neuroscience letters·1992
Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights.
British journal of pharmacology·2026
Photodynamic antimicrobial efficacy and mode of action of polypyridyl-based Ru(II) complexes against multidrug-resistant Klebsiella pneumoniae.
British journal of pharmacology·2026
Selective excitatory effects of γ-glutamyl-glycine, a glutathione metabolite, on GluN1 NMDA and mGlu5 receptors impacting synaptic plasticity.
British journal of pharmacology·2026
Exploring the therapeutic potential of Astragalin in Parkinson's disease: a network pharmacology approach.
Annals of medicine and surgery (2012)·2026